Alec Barclay

Track

Insider profile

Currently holds a position at T2 Biosystems Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -50% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President - Operations T2 Biosystems Inc March 6, 2018 -
Alec Barclay's trades of T2 Biosystems Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
271.26
Quantity 42,556 -15.7%
Value US$752,473
Transaction date
Planned sale
Price
364.09
Quantity 79,987 +8.1%
Value US$1,591,467
Transaction date
Planned sale
Price
117.58
Quantity 34,159 +7.0%
Value US$1,909,035
Transaction date
Planned sale
Price
0.82
Quantity 5,808 -11.1%
Value US$4,763
Transaction date
Planned sale
Price
2.92
Quantity 4,210 -9.1%
Value US$12,293
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-11 2022-04-08
B Purchase
42,556 -15.7%
271.26
US$752,473 		42,556 -15.7% 271.26 US$752,473
2021-03-18 2021-03-17
PlS Planned sale
79,987 +8.1%
364.09
US$1,591,467 		79,987 +8.1% 364.09 US$1,591,467
2021-02-23 2021-02-23
PlS Planned sale
34,159 +7.0%
117.58
US$1,909,035 		34,159 +7.0% 117.58 US$1,909,035
2020-02-25 2020-02-24
PlS Planned sale
5,808 -11.1%
0.82
US$4,763 		5,808 -11.1% 0.82 US$4,763
2019-09-13 2019-09-11
PlS Planned sale
4,210 -9.1%
2.92
US$12,293 		4,210 -9.1% 2.92 US$12,293